IC
TMO icon

IEQ Capital’s Thermo Fisher Scientific TMO Stock Holding History

IEQ Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Sell
4,707
-11,702
-71% -$5.62M 0.01% 743
2026
Q1 		$8.07M Sell
16,409
-8,958
-35% -$4.86M 0.04% 400
2025
Q4 		$14.7M Sell
25,367
-2,064
-8% -$1.17M 0.04% 259
2025
Q3 		$13.3M Sell
27,431
-2,532
-8% -$1.18M 0.04% 263
2025
Q2 		$12.1M Sell
29,963
-13,006
-30% -$5.44M 0.07% 209
2025
Q1 		$21.4M Buy
42,969
+5,798
+16% +$3.14M 0.17% 89
2024
Q4 		$19.3M Sell
37,171
-1,562
-4% -$859K 0.19% 73
2024
Q3 		$24M Buy
38,733
+524
+1% +$310K 0.29% 53
2024
Q2 		$21.1M Buy
38,209
+2,667
+8% +$1.53M 0.28% 53
2024
Q1 		$20.7M Buy
35,542
+2,656
+8% +$1.49M 0.3% 55
2023
Q4 		$17.5M Sell
32,886
-2,098
-6% -$1.02M 0.29% 55
2023
Q3 		$17.7M Buy
34,984
+1,230
+4% +$655K 0.36% 52
2023
Q2 		$17.6M Buy
33,754
+492
+1% +$265K 0.36% 51
2023
Q1 		$19.2M Buy
33,262
+1,610
+5% +$907K 0.44% 42
2022
Q4 		$17.4M Buy
31,652
+662
+2% +$351K 0.49% 35
2022
Q3 		$15.7M Buy
30,990
+2,351
+8% +$1.32M 0.43% 40
2022
Q2 		$15.6M Sell
28,639
-1,717
-6% -$945K 0.47% 40
2022
Q1 		$17.9M Buy
30,356
+4,130
+16% +$2.37M 0.43% 42
2021
Q4 		$17.5M Buy
26,226
+913
+4% +$570K 0.4% 45
2021
Q3 		$14.5M Buy
25,313
+481
+2% +$264K 0.38% 44
2021
Q2 		$12.5M Sell
24,832
-1,784
-7% -$842K 0.37% 44
2021
Q1 		$12.1M Buy
26,616
+5,051
+23% +$2.41M 0.5% 38
2020
Q4 		$10M Sell
21,565
-4,102
-16% -$1.92M 0.45% 46
2020
Q3 		$11.3M Buy
25,667
+982
+4% +$406K 0.61% 32
2020
Q2 		$8.94M Buy
24,685
+8,081
+49% +$2.71M 0.58% 34
2020
Q1 		$4.71M Buy
16,604
+11,064
+200% +$3.49M 0.38% 41
2019
Q4 		$1.8M Buy
+5,540
New +$1.68M 0.16% 99

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

IEQ Capital's TMO Position: Q2 2026 in Review

IEQ Capital reduced its Thermo Fisher Scientific (TMO) stake by 71% in Q2 2026, selling an estimated $5.62M and leaving 4,707 shares worth $2.36M. The position accounts for 0.01% of the portfolio, ranked #743.

IEQ Capital first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $24M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • IEQ Capital held 4,707 shares of Thermo Fisher Scientific worth $2.36M as of Q2 2026.
  • IEQ Capital sold 11,702 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.62M.
  • Thermo Fisher Scientific made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #743 holding.
  • IEQ Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • IEQ Capital's Thermo Fisher Scientific position peaked at $24M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.